Your browser doesn't support javascript.
loading
Diclofenac exhibits cytotoxic activity associated with metabolic alterations and p53 induction in ESCC cell lines and decreases ESCC tumor burden in vivo.
Kabir, Mohammad Faujul; Jackson, Jazmyne L; Fuller, Annie D; Gathuka, Leonny; Karami, Adam L; Conde, Don-Gerard; Klochkova, Alena; Mu, Anbin; Cai, Kathy Q; Klein-Szanto, Andres J; Muir, Amanda B; Whelan, Kelly A.
Afiliação
  • Kabir MF; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Jackson JL; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Fuller AD; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Gathuka L; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Karami AL; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Conde DG; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Klochkova A; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Mu A; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
  • Cai KQ; Histopathology Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Klein-Szanto AJ; Histopathology Facility, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Muir AB; Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Whelan KA; Fels Cancer Institute for Personalized Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Carcinogenesis ; 44(2): 182-195, 2023 05 26.
Article em En | MEDLINE | ID: mdl-37014121
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_digestive_diseases / 6_esophagus_cancer Assunto principal: Neoplasias Esofágicas / Diclofenaco / Carcinoma de Células Escamosas do Esôfago / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Carcinogenesis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_digestive_diseases / 6_esophagus_cancer Assunto principal: Neoplasias Esofágicas / Diclofenaco / Carcinoma de Células Escamosas do Esôfago / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Carcinogenesis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos